Vbi Vaccines Inc (VBIV) Annual Balance Sheets

Annual · GAAP · USD millions
Access VBIV quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Vbi Vaccines Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent23.69
Short-term Investments, Total0.00
Cash & Short-term Investments23.00
Accounts receivable0.00
Inventories1.66
Derivatives, Collateral, Regulatory, Deferred0.96
Other Current Assets1.76
Prepaid Expense, Current AS2.28
Total Current Assets36.23
Equipment/Property/Plant Net9.67
Goodwill net1.13
Intangible Assets36.50
Tax Assets, Noncurrent-9.67
Other Assets, Noncurrent2.00
Operating Lease Right Of Use Asset2.25
Total Assets86.95
Liabilities
Accounts Payable, Current AC6.43
Employee-related Liabilities AC1.67
Long-term Debt, Current Maturities LO50.77
Other Liabilities, Current18.54
Deferred Revenue, Current DE0.00
Total Current Liabilities75.74
Long-term debt50.77
Long-term Debt Convertible0.00
Total Long-term Debt50.77
Other liabilities, Noncurrent0.00
Contract With Customer Liability Current7.28
Contract With Customer Liability Noncurrent1.83
Operating Lease Liability Noncurrent1.30
Total Liabilities126.51
Stockholders' Equity
Common Stock Value454.21
Additional Paid In Capital Common Stock107.43
Retained Earnings / Accumulated Deficit-582.45
Accumulated Other Comprehensive Income28.33
Other Equity28.33
Common Stockholder's Equity7.53
Total Stockholder's Equity7.53
Liabilities & Stockholder's Equity86.95
4 historic quarters locked

Sign in to unlock the full Vbi Vaccines Inc balance sheet history.

About Vbi Vaccines Inc bc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: April 16, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-014744

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License